Covid-19: Zydus seeks DCGI nod to undertake clinical trials for monoclonal antibodies cocktail

Zydus Cadila on Thursday said it is seeking permission from Drugs Controller General of India (DCGI) to initiate human clinical trials for monoclonal antibodies cocktail for treatment of COVID-19.

from IndiaTV India: Google News Feed https://ift.tt/3yHpXKk

Comments